Unique ID issued by UMIN | UMIN000027599 |
---|---|
Receipt number | R000031198 |
Scientific Title | Efficacy of inside metallic stent for benign biliary stricture which persisted after plastic stenting: Multicenter prospective observational study |
Date of disclosure of the study information | 2017/06/01 |
Last modified on | 2022/01/31 17:08:21 |
Efficacy of inside metallic stent for benign biliary stricture which persisted after plastic stenting: Multicenter prospective observational study
Efficacy of inside metallic stent for benign biliary stricture
Efficacy of inside metallic stent for benign biliary stricture which persisted after plastic stenting: Multicenter prospective observational study
Efficacy of inside metallic stent for benign biliary stricture
Japan |
Benign biliary stricture
Hepato-biliary-pancreatic medicine |
Others
NO
To evaluate the efficacy of inside metallic stent for benign biliary stricture which persisted after plastic stent placement.
Safety,Efficacy
Rate of stricture resolution at metallic stent removal after 4 month stent placement
1.Success rate of stent placement
2.Success rate of stent removal
3. Rate of stricture recurrence
4. Adverse events
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients with refractory benign biliary strictures (Resolution of stricture was not achieved by plastic stent treatment).
2.Malignancy is ruled out by pathological examination and clinical course.
3.Biliary stricture was completely existed on ERC findings, or no flow of contrast material into the downstream within 60 seconds, if stenosis was incomplete.
4.Biliary strictures located above the ampulla 15 mm or more upstream.(Metallic stent could be placed inside the bile duct )
1.Patients with performance status 3 or 4
2.Patients with severe complications to other organs.
3.Stricture of intrahepatic bile duct
4.Age<20
5.Patients without informed concent
6.The size of bile duct size showed less than 8 mm on first ERC finding.
7.Patients with severe coagulation dysfunction.
8.Patients with hepaticojejunostomy
9.Patients judged inappropriate by chief medical examiner.
60
1st name | Hironari |
Middle name | |
Last name | Kato |
Okayama University Hospital
Department of Gastroenterology
7008558
2-5-1 Shikata-cho,Kita-ku Okayama-city Okayama
086-235-7219
drkatocha@yahoo.co.jp
1st name | Kazuyuki |
Middle name | |
Last name | Matsumoto |
Okayama University Hospital
Department of Endoscopy
7008558
2-5-1 Shikata-cho,Kita-ku Okayama-city Okayama
086-235-7219
matsumotokazuyuki0227@yahoo.co.jp
Okayama University Hospital
Department of Gastroenterology
none
Other
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
2-5-1,shikata-cho, okayama city, okayama
086-235-7219
mae6605@adm.okayama-u.ac.jp
NO
2017 | Year | 06 | Month | 01 | Day |
Unpublished
22
The technical success rate of intraductal FCSEMS placement was 100%
The rate of successful stent removal at four months was 100% and stricture resolution was observed in 91% of patients.
Bile leak due to guidewire injury occurred in one patient, but stent migration or stent-induced de novo stricture did not occur in any patient.
The stricture recurrence rate was 16%, and the median(interquartile range)follow-up duration was 2.8(1.6-3.3)years.
1-year and 2-year recurrence free rate were 89% and 84%
2022 | Year | 01 | Month | 31 | Day |
Completed
2017 | Year | 05 | Month | 23 | Day |
2017 | Year | 05 | Month | 12 | Day |
2017 | Year | 05 | Month | 23 | Day |
2021 | Year | 07 | Month | 30 | Day |
2021 | Year | 08 | Month | 30 | Day |
2021 | Year | 09 | Month | 30 | Day |
2021 | Year | 12 | Month | 31 | Day |
Observation period: 12 month(after metallic stent removal)
2017 | Year | 06 | Month | 01 | Day |
2022 | Year | 01 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031198